R
RGNT
Regentis Biomaterials Ltd
3.100
+0.045+1.47%Closed15:42 04/10 EDT
OPEN/PREV CLOSE3.100/3.055
TODAY RANGE3.000-3.100
VOL4.16K
MARKET CAP16.06M
52 WEEK RANGE2.800-8.35
AVG VOL (3M)18.93K
% TURNOVER0.08%
TURNOVER--
P/E (TTM)-0.1287
% RANGE1.64%
EPS(TTM)-24.0816
P/E(FORWARD)--
P/B3.385
BVPS0.9159
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.88M
SHARES OUTSTANDING5.18M
NEXT EARNINGS--
FREE FLOAT1.25M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·03/17 13:07
Regentis Biomaterials develops and patents solvent-free manufacturing process
TipRanks·03/02 11:39
Regentis Biomaterials initiated with a Buy at ThinkEquity
Seeking Alpha·02/24 21:39
Regentis Biomaterials Ltd. reports FY results
TipRanks·02/19 13:57
Regentis Biomaterials appoints Galit Reke as CMO
TipRanks·02/17 13:45
Regentis Biomaterials expands European clinical site network
TipRanks·02/04 14:01
Regentis Biomaterials appoints Ori Gon as CFO, CBO
Seeking Alpha·02/04 13:56
Regentis Biomaterials appoints new CFO
TipRanks·01/29 13:50
Regentis Biomaterials expanding Phase III GelrinC clinical site network
TipRanks·01/28 16:25
Regentis Biomaterials Ltd trading resumes
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.